A Case of Kaposi's Sarcoma Following Treatment of Membranoproliferative Glomerulonephritis and a Review of the Literature

References

• Penn I. Kaposi’s sarcoma in transplant recipients. Transplantation 1997; 64: 669–673
   PubMedGoogle Scholar
• Hood AF, Farmer ER. Kaposi sarcoma. Medicine Jul, 1993; 72(4)245–261
   PubMedGoogle Scholar
• Cheung MC, Pantanowitz L, Dezube BJ. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy. Oncologist Jun–Jul, 2005; 10(6)412–426
   PubMedGoogle Scholar
• Louthrenoo W, Kasitanon N, Mahanuphab P, Bhoopat L, Thongprasert S. Kaposi’s sarcoma in rheumatic diseases. Semin Arthritis Rheum Apr, 2003; 32(5)326–333
   PubMedGoogle Scholar
• Jensen P, Hansen S, Moller B, et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999; 40: 177–186
   PubMed Web of Science ®Google Scholar
• Hoff M, Rodevand E. Development of multiple malignancies after immunosuppression in a patient with Wegener’s granulomatosis. Rheumatol Int Apr, 2005; 25(3)238–240
   PubMedGoogle Scholar
• Boshoff C, Weiss RA. Epidemiology and pathogenesis of Kaposi’s sarcoma-associated herpes virus. Philos Trans R Soc Lond Biol Sci 2001; 356: 517–534
   PubMed Web of Science ®Google Scholar
• Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Eng J Med Apr, 2003; 348(17)1681–1691
   PubMed Web of Science ®Google Scholar
• Boeckle E, Boesmueller C, Wiesmayr S, Mark W, Rieger M, Tabarelli D, Graziadei I, Hoefer D, Antretter H, Stelzmueller I, Krugmann J, Zangerle R, Huemer H, Poelzl G, Margreiter R, Bonatti H. Kaposi sarcoma in solid organ transplant recipients: a single center report. Transplant Proc May, 2005; 37(4)1905–1909
   PubMedGoogle Scholar
• Duman S, Toz H, Asci G, Alper S, Ozkahya M, Unal I, Celik A, Ok E, Basci A. Successful treatment of post-transplant Kaposi’s sarcoma by reduction of immunosuppression. Nephrol Dial Transplant May, 2002; 17(5)892–896
   PubMedGoogle Scholar
• Huang JY, Chiang YJ, Lai PC, Shih LY, Huang CC, Chu SH, Wu CH. Posttransplant Kaposi’s sarcoma: report from a single center. Transplant Proc Sep, 2004; 36(7)2145–47
   PubMedGoogle Scholar
• Moray G, Basaran O, Yagmurdur MC, Emiroglu R, Bilgin N, Haberal M. Immunosuppressive therapy and Kaposi’s sarcoma after kidney transplantation. Transplant Proc Jan–Feb, 2004; 36(1)168–170
   PubMedGoogle Scholar
• Pedotti P, Cardillo M, Rossini G, Arcuri V, Boschiero L, Caldara R, Cannella G, Dissegna D, Gotti E, Marchini F, Maresca MC, Montagnino G, Montanaro D, Rigotti P, Sandrini S, Taioli E, Scalamogna M. Incidence of cancer after kidney transplant: results from the North Italy transplant program. Transplantation Nov 27, 2003; 76(10)1448–1451
   PubMedGoogle Scholar
• Trattner A, Hodak E, David M, Sandbank M. The appearance of Kaposi sarcoma during corticosteroid therapy. Cancer Sep 1, 1993; 72(5)1779–1783
   PubMed Web of Science ®Google Scholar
• Pellet C, Chevret S, Francès C, et al. Prognostic value of quantitative Kaposi sarcoma-associated herpes virus load in posttransplantation Kaposi sarcoma. J Infect Dis 2002; 186: 110–113
   PubMedGoogle Scholar
• Marcelin AG, Milliancourt C, Dupin N, Wirden M, Huraux JM, Agut H, Calvez V. Effects of cyclosporine and hydrocortisone on Kaposi’s sarcoma-associated herpes virus genome replication and cell apoptosis induction. Transplantation Nov 27, 2001; 72(10)1700–1703
   PubMedGoogle Scholar
• Vandercam B, Lachapelle JM, Janssens P, Tennstedt D, Lambert M. Kaposi’s sarcoma during immunosuppressive therapy for atopic dermatitis. Dermatology 1997; 194(2)180–182
   PubMed Web of Science ®Google Scholar
• Gaspari AA, Marchese S, Powell D, Rady PL, Tyring SK. Identification of HHV-8 DNA in the skin lesions of Kaposi’s sarcoma in an immunosuppressed patient with bullous pemphigoid. J Am Acad Dermatol Nov, 1997; 37(5 Pt 2)843–847
   PubMedGoogle Scholar
• Kaplan RP, Israel SR, Ahmed AR. Pemphigus and Kaposi’s sarcoma. J Dermatol Surg Oncol Oct, 1989; 15(10)1116–1121
   PubMedGoogle Scholar
• Toyohama T, Nagasaki A, Miyagi J, Takamine W, Sunagawa K, Uezato H, Taira N, Masuda M, Takasu N. Kaposi’s sarcoma in a human immunodeficiency virus-negative patient treated with corticosteroid for idiopathic thrombocytopenic purpura. Intern Med May, 2003; 42(5)448–449
   PubMedGoogle Scholar
• Cohen RL, Tepper RE, Urmacher C, Katz S. Kaposi’s sarcoma and cytomegaloviral ileocolitis complicating long-standing Crohn’s disease in an HIV-negative patient. Am J Gastroenterol Oct, 2001; 96(10)3028–3031
   PubMedGoogle Scholar
• Bursics A, Morvay K, Abraham K, Marschalko M, Kardos M, Jaray B, Nagy K. HHV-8 positive, HIV negative disseminated Kaposi’s sarcoma complicating steroid dependent ulcerative colitis: a successfully treated case. Gut Jul, 2005; 54(7)1049–1050
   PubMedGoogle Scholar
• Brenner BM, Levine SA. Brenner and Rector’s The Kidney 7th. Saunders, Philadelphia, 1322–1327
   Google Scholar
• Baris YS, Akpolat T, Akpolat I, Karagöz F, Kandemir B. Coexistence of membranous glomerulonephritis and Kaposi’s sarcoma. Nephron Jul, 1998; 79(3)371–372
   PubMedGoogle Scholar
• Freuler CB, Durlach RA, Toblli JE, Cicco J, Casas J. Kaposi’s sarcoma in young adults without evidence of HIV infection. Medicina (B Aires) 1994; 54(2)145–149
   PubMedGoogle Scholar
• Zerbi S, Saruggia M, Brambilla L, Lodeville D, Buccianti G. Kaposi’s sarcoma in a patient with focal glomerulosclerosis. J Nephrol 2001; 14: 299–303
   PubMedGoogle Scholar
• Chim CS, Lam KY, Chan KW. Castleman’s disease with Kaposi’s sarcoma and glomerulonephritis. Am J Med Aug, 1999; 107(2)186–188
   PubMedGoogle Scholar